
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [FOLD] Amicus Therapeutics Inc
Data updated 2024-May-17 (Friday)Compare current performance/technical metrics to history for Amicus Therapeutics Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2024-May-17 Friday
Day Change | +0.74% Mid | Day Volatility | 2.68% Low |
Streak | ↑ 1 day Mid | % Streak | +0.74% Mid |
RSI | 38 Low | CCI | -85.0 Mid |
MACD | 0.0 Mid | ATR | 0.4 Mid |
ADX | 32.2 Top | SSO | 25.5 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +3.68% Mid | 8.65% Mid | +1.59% Mid |
10-day | -7.98% Low | 17.18% Mid | -1.04% Mid |
20-day | -9.80% Low | 21.18% Mid | -4.65% Low |
50-day | -22.13% Low | 39.80% Mid | -12.03% Low |
100-day | -29.63% Low | 61.53% Mid | -20.58% Low |
200-day | -29.42% Low | 61.53% Mid | -19.88% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2024-May-17, Amicus Therapeutics Inc had:daily change of +0.74% intraday volatility of 2.7% 1 ↑(up) day streak yielding +0.74% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2024-May-17 value annotated for comparison
Related to Amicus Therapeutics Inc
Information for Amicus Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-12 on Google
SEC Reports : Quarterly reports around 2025-May-12 on SEC Edgar
Compare Amicus Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Amicus Therapeutics Inc
Industry : Biotechnology industry performance which includes Amicus Therapeutics Inc